Document is current

Article History

Received: 30 May 2024

Accepted: 15 August 2024

First Online: 31 August 2024

Declarations

:

: The authors thank all investigators and research staff in participating institutions. The authors thank Erin O’Neil, MSc, and Ellie Fung, BSc, of Costello Medical, for medical writing support, which was sponsored by Ipsen in accordance with Good Publication Practice guidelines. The authors also thank Parexel for statistical analysis support, which was sponsored by Ipsen and conducted in accordance with Good Pharmacoepidemiology Practice and International Conference on Harmonization guidelines.

: Jen-Shi Chen has received research funding from Amgen, Astellas Pharma, AstraZeneca, Janssen, Merck KGaA, MSD Oncology, Ono Pharmaceutical, Roche, Senhwa Biosciences, and TTY Biopharm. Stephen Lam Chan has received research funding from Ipsen. Ji-Yan Zou, Xiaofeng Shi, Aude Houchard, and Xuan-Mai Truong Thanh are employees of Ipsen. Li-Yuan Bai, Hsiao-Hsiang Cheng, and Ming-Huang Chen declare that they have no competing interests.

: This study is noninterventional, and therefore falls outside the scope of the European Union (EU) Directive 2001/20/EC and the EU Directive 2005/28/EC. Approval for this study was granted from the local Independent Ethics Committees or Institutional Review Boards [Joint Chinese University of Hong Kong-New Territories East Cluster Clinical Research Ethics Committee (approval number: 2021.629), Chang Gung Medical Foundation Institutional Review Board (approval number: 202101850B0), Taipei Veterans General Hospital Institutional Review Boards (approval number: 2022–01-001BCU), China Medical University Hospital Research Ethics Committee (approval number: CMUH110-REC3-210), Institutional Review Board Committee Koo Foundation Sun Yat-Sen Cancer Center (approval number: 20220308A)]. This study was conducted in accordance with the recommendations of the Declaration of Helsinki and the International Ethical Guidelines for Epidemiological Studies. Informed consent was obtained from patients prior to enrollment and prior to any data collection. Informed consent was waived for some patients because of the retrospective nature of this study, and when applicable on the respective site per local regulation.